Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
NCT00152594
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Myelocytic, Acute
Interventions
DRUG:
voriconazole
Sponsor
University of Cologne